Exeter's company SENISCA raises £2 million to treat age-related chronic diseases
University of Exeter - 09-Jun-2022Funding might allow RNA-based rejuvenation tech to enter ex vivo lab tests
Kirsty Semple
Chief Executive Officer and Co-founder of SENISCA
Kirsty Semple is working as Chief Executive Officer for SENISCA Ltd, a high growth biotech spinout from the University of Exeter. He has over 25 years experience managing high performance teams at prestigious UK and US organisations. Kirsty is the commercial, finance and investment lead at SENISCA. Kirsty trained as a Management Consultant with KPMG London and is a prize-winning Cell Physiology graduate from Edinburgh University.
Visit website: https://www.senisca.com/#the-team/#kirsty
See also: 
SENISCA
- University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing
Details last updated 13-Mar-2021
Kirsty Semple is also referenced in the following:
SENISCA
University of Exeter spinout developing senotherapeutic interventions through modulation of dysregulated RNA splicing
Kirsty Semple News
SENISCA secures 1.3 million pounds to transform anti-ageing technology
University of Exeter - 12-Mar-2021Spin out company from University of Exeter step forward towards precision medicine for age-related diseases
